Curian Capital’s West Pharmaceutical WST Stock Holding History

Curian Capital’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,527	Closed	-$212K	–	383
2015 Q4	$212K	Sell	3,527 -6,293	-64%	-$379K	0.02%	453
2015 Q3	$531K	Sell	9,820 -3,800	-28%	-$221K	0.01%	482
2015 Q2	$791K	Sell	13,620 -905	-6%	-$50.5K	0.01%	511
2015 Q1	$875K	Buy	14,525 +36	+0.2%	+$1.92K	0.01%	484
2014 Q4	$771K	Buy	14,489 +300	+2%	+$15K	0.01%	503
2014 Q3	$635K	Buy	14,189 +343	+2%	+$14.6K	0.01%	515
2014 Q2	$584K	Buy	+13,846	New	+$593K	0.01%	541

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Curian Capital's WST Position: Q1 2016 in Review

Curian Capital sold out of West Pharmaceutical (WST) in Q1 2016, closing a stake of 3,527 shares — an estimated $212K sold.

Curian Capital first reported a position in WST in Q2 2014 and held it in 7 quarters. The position peaked at $875K in Q1 2015. 250 funds tracked by Wall St. Rank hold WST as of Q1 2016.

Curian Capital reported no remaining West Pharmaceutical position as of Q1 2016 after selling out during the quarter.
Curian Capital sold 3,527 West Pharmaceutical shares in Q1 2016, an estimated $212K.
Curian Capital first reported a position in West Pharmaceutical in Q2 2014 and held it in 7 quarters.
Curian Capital's West Pharmaceutical position peaked at $875K in Q1 2015.
250 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.